Cerebrospinal Fluid β-Amyloid Turnover in the Mouse, Dog, Monkey and Human Evaluated by Systematic Quantitative Analyses
Yasong Lu(Pfizer (United States)), David Riddell(Eli Lilly (United States)), Liming Zhang(Air Force General Hospital PLA), Kathleen M. Wood, Hugh A. Barton, Charles E. Nolan(Pfizer (United States)), Ashley Robshaw(Pfizer (United States)), Jianhua Liu(Tangshan College), Brian T. O’Neill(Pfizer (United States)), Stacey L. Becker(Pfizer (United States)), Louis Leung(Merck & Co., Inc., Rahway, NJ, USA (United States)), Éva Hajós‐Korcsok(Pfizer (United States)), Christine K. Taylor, Michael A. Brodney(Vertex Pharmaceuticals (United States))
Cited by 21
Related Papers
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
|Journal of Medicinal Chemistry|2012|460
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
|Journal of Neuroscience|2008|351
Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts
|Current Biology|2001|302
The LXR agonist TO901317 selectively lowers hippocampal Aβ42 and improves memory in the Tg2576 mouse model of Alzheimer's disease
|Molecular and Cellular Neuroscience|2007|248